International Vaccine Institute
The International Vaccine Institute (IVI) is an international organization exclusively devoted to vaccine research and development for people in developing countries, especially children. It was established at the initiative of the United Nations Development Programme(UNDP) under the Vienna Convention 1969 with the signatures so far of 40 countries and the World Health Organization (WHO) The IVI is headquartered in Seoul, Korea.
Achievements
- IVI has developed 3 new or improved vaccines: reformulated oral cholera vaccine, typhoid Vi polysaccharide vaccine, and typhoid Vi conjugate vaccine.
- IVI was the first to identify that Japanese encephalitis is a major problem in Bali, Indonesia.
- IVI and the National Institute of Cholera and Enteric Diseases(NICED) jointly established a major vaccine study site in Kolkata, India.
- IVI scientists developed the first animal model of Shigella colitis for use in developing a Shigella vaccine.
- Since 2000, IVI has hosted an annual International Advanced Course on Vaccinology for the Asia-Pacific Region to build country capacity in vaccine-related research.
- IVI demonstrated for the first time that killed oral cholera vaccine is effective in populations with high rates of HIV/AIDS(Mozambique).
External links